Androgen deprivation therapy does not impact cause-specific or overall survival in high-risk prostate cancer treated with brachytherapy and supplemental external beam

被引：0
|
作者：
Allen, Z.
Merrick, G. S.
Butler, W.
Wallner, K.
Galbreath, R.
Adamovich, E.
Lief, J.
机构：
[1] Wheeling Hosp, Wheeling, WV USA
[2] Puget Sound Healthcare Cooperat, Grp Hlth, Seattle, WA USA
[3] Ohio Univ Eastern, St Clairsville, OH USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
15578
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Radiation Facility Volume and Survival for Men With Very High-Risk Prostate Cancer Treated with Radiation and Androgen Deprivation Therapy
    Sebastian, Nikhil
    Goyal, Subir
    Liu, Yuan
    Janopaul-Naylor, James R.
    Patel, Pretesh R.
    Dhere, Vishal R.
    Hanasoge, Sheela
    Shelton, Jay W.
    Godette, Karen D.
    Jani, Ashesh B.
    Hershatter, Bruce
    Fischer-Valuck, Benjamin
    Patel, Sagar A.
    JAMA NETWORK OPEN, 2023, 6 (08) : e2327637
  • [42] Heterogeneity in high-risk prostate cancer treated with high-dose radiation therapy and androgen deprivation therapy
    Cagney, Daniel N.
    Dunne, Mary
    O'Shea, Carmel
    Finn, Marie
    Noone, Emma
    Sheehan, Martina
    McDonagh, Lesley
    O'Sullivan, Lydia
    Thirion, Pierre
    Armstrong, John
    BMC UROLOGY, 2017, 17
  • [43] Heterogeneity in high-risk prostate cancer treated with high-dose radiation therapy and androgen deprivation therapy
    Daniel N. Cagney
    Mary Dunne
    Carmel O’Shea
    Marie Finn
    Emma Noone
    Martina Sheehan
    Lesley McDonagh
    Lydia O’Sullivan
    Pierre Thirion
    John Armstrong
    BMC Urology, 17
  • [44] The impact of body mass index on cause-specific biochemical and overall survival following permanent prostate brachytherapy
    Merrick, G.
    Butler, W.
    Wallner, K.
    Galbreath, R.
    Allen, Z.
    Adamovich, E.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (03): : S362 - S363
  • [45] Treatment timing in localized high-risk prostate cancer treated with radiation and androgen deprivation therapy
    Hasan, Shaakir
    Lazarev, Stanislav
    Gorovets, Daniel
    Garg, Madhur
    Press, Robert H.
    Choi, Isabelle
    Simone, Charles B.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [46] Assessing the Optimum Use of Androgen-Deprivation Therapy in High-Risk Prostate Cancer Patients Undergoing External Beam Radiation Therapy
    Ludwig, Michelle S.
    Kuban, Deborah A.
    Strom, Sara S.
    Du, Xianglin L.
    Lopez, David S.
    Yamal, Jose-Miguel
    AMERICAN JOURNAL OF MENS HEALTH, 2017, 11 (01) : 73 - 81
  • [47] Impact of androgen deprivation therapy on survival in men treated with radiation for prostate cancer
    Pollack, A
    Kuban, DA
    Zagars, GK
    UROLOGY, 2002, 60 (3A) : 22 - 30
  • [48] Recent Trends in the Use of Androgen Deprivation Therapy with External Beam Radiation Therapy for Patients with Intermediate- and High-Risk Prostate Cancer
    Yang, D. D.
    Orio, P. F., III
    Nguyen, P. L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : E151 - E152
  • [49] The Addition of Low-dose-rate Brachytherapy and Androgen Deprivation Therapy Decreases Prostate Cancer Death Compared to Dose-escalated External Beam Radiation Therapy for High-risk Prostate Cancer
    Shilkrut, M.
    McLaughlin, W. P.
    Stenmark, M. H.
    Abu-Isa, E.
    Vance, S. M.
    Sandler, H. M.
    Evans, C.
    Feng, F. Y.
    Merrick, G. S.
    Hamstra, D. A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S149 - S149
  • [50] Interval to biochemical failure as a biomarker for cause-specific and overall survival after dose-escalated external beam radiation therapy for prostate cancer
    Kapadia, Nirav S.
    Olson, Karin
    Sandler, Howard M.
    Feng, Felix Y.
    Hamstra, Daniel A.
    CANCER, 2012, 118 (08) : 2059 - 2068
12345